Virtual Meet: Ozempic-Like Drugs to Fight Obesity-Cancer Link
Published Date: 10/6/2026
Notice
Summary
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Virtual public meeting on GLP-1 and cancer risk
You can join a virtual public meeting of the President's Cancer Panel on October 15, 2026, from 9:00 a.m. to 1:00 p.m. ET to hear about Opportunities to Reduce Obesity-Related Cancer Risk: GLP-1 Medications. Registration is not required and the meeting is accessible at https://cbiit.webex.com/weblink/register/r8def1cffd7e6e17a9b599f8f3c6e9441.
You may submit written comments beforehand
You may file written comments with the committee by sending a statement to the Contact Person (Samantha L. Finstad, Ph.D.). Statements should include your name, address, telephone number, and, if applicable, your business or professional affiliation.
Reasonable accommodations available if requested
If you plan to view the virtual meeting and need special assistance or other reasonable accommodations, you should notify the Contact Person in advance (Samantha L. Finstad, Ph.D., 240-276-6460, [email protected]).
Meeting agenda and access info to be posted online
You can find additional information, the agenda, and instructions for accessing the virtual meeting on the President's Cancer Panel website at https://prescancerpanel.cancer.gov/, where materials will be posted when available.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-23010, Privacy Act of 1974; System of Records
The National Institutes of Health (NIH) is updating its Privacy Act system that manages library user records to keep things current and clear. These changes affect who’s covered, what info is kept, where it’s stored, and how long it’s kept. You’ve got until December 14, 2026, to share your thoughts, and no extra costs are involved—just smoother privacy rules for NIH library users!
2026-22871, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for eye disease, neuronal injury, infectious diseases, and related projects. No public access is allowed to protect private info and trade secrets, but these reviews help decide who gets research money.
2026-22550, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings on November 30, 2026, to review important grant applications. These meetings affect researchers applying for funding in cardiovascular sciences and tobacco regulatory science. No public access is allowed to protect private info and trade secrets, and the reviews help decide who gets research money.
2026-22558, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for health-related projects, ensuring privacy for sensitive information. No direct money changes are announced, but these reviews help decide who gets research grants.
2026-22339, Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.
2026-22196, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public meeting on May 12, 2027, to discuss important council business and review grant applications. People interested can attend in person or online, but space is limited and some parts of the meeting will be private to protect sensitive information. This meeting affects researchers and organizations seeking funding and sets the stage for future diabetes and kidney disease research support.
Previous / Next Documents
Previous: 2026-20423, Meeting of the Chief Freedom of Information Act Officers Council
The Chief Freedom of Information Act (FOIA) Officers Council is holding a virtual meeting on October 22, 2026, to discuss how government agencies handle public information requests. Anyone interested can join online by registering in advance, and the meeting will include chances to share public comments. This event affects government transparency efforts and helps improve how quickly and clearly agencies respond to FOIA requests, with no direct costs involved.
Next: 2026-20425, Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just blocked the property of Rafael Buenrostro Martin and others for their roles in illegal drug trade and terrorism. From September 29, 2026, Americans can’t do business with these folks, freezing their assets under U.S. law. This move aims to cut off their money flow and stop bad activities fast and firmly.